BIOSEARCH TECHNOLOGIES, INC.

BIOSEARCH TECHNOLOGIES, INC. specializes in the design, development, and GMP-compliant manufacturing of molecular diagnostic reagents, including primers, probes, and multiplex PCR kits for infectious disease detection. The company’s technical expertise centers on synthetic oligonucleotide production, dual-labeled probe engineering, and high-purity chemical synthesis under controlled environments, with demonstrated proficiency in supporting Emergency Use Authorizations (EUAs) and in-vitro diagnostic (IVD) regulatory pathways. Their work directly enables rapid pathogen identification, including for influenza, Yersinia pestis, and SARS-CoV-2, leveraging precision chemistry to deliver scalable, reliable molecular tools for public health and defense applications. The contractor maintains a strong, sustained relationship with the Department of Health and Human Services, consistently delivering critical diagnostic components for CDC-led surveillance and response initiatives. They also support the Department of Defense with specialized molecular probes for biothreat detection, indicating a dual-use capability aligned with national security and civilian health priorities. Their contract history reflects deep engagement with federal public health infrastructure, particularly in crisis-response scenarios requiring rapid reagent deployment. BIOSEARCH operates primarily within the 325199 and 325413 NAICS categories, focusing on the manufacturing of organic chemical intermediates for molecular diagnostics and GMP-grade IVD substances. This positions them as a niche supplier in the infectious disease diagnostics supply chain, serving government laboratories and public health networks that require high-specificity, low-contamination reagents for PCR-based assays. Their market role is that of a precision chemistry partner for mission-critical diagnostic systems. As a small business structured as a 2L entity based in Petaluma, California, BIOSEARCH TECHNOLOGIES, INC. operates without formal government certifications but maintains a focused presence in the federal life sciences procurement market. Their geographic location supports access to West Coast biotech infrastructure and federal research hubs, reinforcing their role as a specialized supplier to U.S. health and defense agencies.